Skip to content
Trending
September 26, 2025CDC takes down more than a dozen webpages on sexual and gender identity, health equity December 5, 2025Rubrik stock rips 22% higher after blowing out earnings and boosting guidance August 11, 2025How dealmaking king Goldman Sachs aims to dominate another corner of Wall Street March 8, 2025Powell says Fed is awaiting ‘greater clarity’ on Trump policies before making next move on rates March 10, 2025RFK Jr. could further deter childhood vaccinations as rates fall in the U.S. November 28, 2025HP Inc shares fall on layoffs, weak guidance due to U.S. trade regulations May 3, 2025Berkshire meeting ‘bazaar’ features Buffett Squishmallows, 60th anniversary book and giant claw machine September 10, 2025Wells Fargo CEO says Trump is entitled to be vocal about the Fed June 14, 2025This credit card behavior is an under-the-radar risk: ‘Be very careful,’ expert says November 30, 2025‘Robotaxi has reached a tipping point’: Baidu, Nvidia leaders see momentum as competition rises
  Thursday 9 April 2026
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
  Earnings  Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening yet
Earnings

Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening yet

AdminAdmin—August 8, 20250
More stories

Salesforce shares fall as software maker shows pockets of weakness

June 19, 2025

Home Depot’s business momentum drives shares higher as investors jump in ahead of Fed rate cuts

August 26, 2025

HSBC announces share buyback of up to $2 billion as annual profit jumps 6.5%

February 19, 2025

American Eagle stock soars 20% as retailer says Sydney Sweeney campaign is ‘best’ to date, beats earnings

October 3, 2025

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Stocks advanced Friday as Wall Street looks to close out a winning week. The S & P 500 and Dow Jones Industrial Average were solidly higher. Meanwhile, the tech-heavy Nasdaq Composite is on track for another record closing high. Next week all eyes will be on a slew of U.S. economic data, most notably on the inflation front. The consumer price index is due out Tuesday morning and carries implications for the Federal Reserve’s next monetary policy move. If inflation has picked up significantly, that could force the market to reconsider its expectations for a cut at the Fed’s September meeting. 2. Wall Street analysts came to Eli Lilly’s defense Friday after the stock plunged 14% Thursday on disappointing late-stage trial data for its obesity pill, which also overshadowed its overall solid quarterly earnings report. “Yesterday was just a disaster of a day,” said Jeff Marks, the Club’s director of portfolio analysis. Morgan Stanley said the sell-off was “overdone.” Meanwhile, JPMorgan argued that the pullback in shares creates a “compelling entry point.” Despite the positive Wall Street chatter, Eli Lilly stock fell another 2.5% during Friday trading. There’s a lot of hesitation to get back into the stock right now. We feel the same way, which is why the Club downgraded to a 3 rating, meaning sell into strength, and lowered our price target to $800 from $1,000. The analyst community is “all getting really behind Eli Lilly, but the investors [are] not quite yet,” Marks added. 3. Meta Platforms has reportedly turned to alternative asset manager Blue Owl Capital and bond giant PIMCO to lead a $29 billion financial deal to help fund the company’s data center expansion. Bloomberg News first reported on the deal. We applaud Meta’s push further into AI. “It really just shows their commitment to AI,” Marks said. “They’re not afraid to really use a lot of their cash flow to support these efforts.” Shares of the social media giant are up slightly on Friday. (Jim Cramer’s Charitable Trust is long LLY, META. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

Dodge unveils additions to 2026 muscle car lineup: ‘It’s about choice’
Trump’s ‘reciprocal’ tariffs come into effect, hitting dozens of U.S. trading partners
Related posts
  • Related posts
  • More from author
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Earnings

Salesforce’s raised guidance lifts the stock but doesn’t change our rating

December 17, 20250
Earnings

Oracle plummets 11% on weak revenue, pushing down AI stocks like Nvidia and CoreWeave

December 16, 20250
Load more
Read also
Finance

Visa says new AI shopping tool has helped customers with hundreds of transactions

December 18, 20250
Economy

Trust these numbers? Economists see a lot of flaws in delayed CPI report showing downward inflation

December 18, 20250
Earnings

Nike tops earnings estimates but shares fall as China sales plunge, tariffs hit profits

December 18, 20250
Business

American Airlines no longer lets basic economy flyers earn miles

December 18, 20250
Finance

Billionaire fund manager Ron Baron praises beaten-up financial stock whose new CEO he compares to Jamie Dimon

December 17, 20250
Economy

Watch Fed Governor Christopher Waller speak on interest rates and the race to succeed Powell

December 17, 20250
Load more
    © 2022, All Rights Reserved.
    • About Us
    • Advertise With Us
    • Contact Us
    • Disclaimer
    • Cookie Law
    • Privacy Policy
    • Terms & Conditions